Patents by Inventor Michael A. Ihnat

Michael A. Ihnat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • In vivo methods of identifying compounds which target suppressed cancer cells
    Patent number: 8101159
    Abstract: In vitro and in vivo methods for identifying compounds capable of targeting suppressed cancer cells such as micrometastatic cells. The in vitro method includes the steps of comparing the response to a test compound of cancer cells grown on a suppressing cell support matrix which causes suppression of a malignant phenotype in a growing cancer cell and on a non-suppressing cell support matrix. The in vivo method includes a step of co-injecting labeled cancer cells with a malignant-phenotype suppressing matrix into a test animal to produce suppressed micrometastatic cells therein.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: January 24, 2012
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Robert E. Hurst, Michael A. Ihnat
  • IN VIVO METHODS OF IDENTIFYING COMPOUNDS WHICH TARGET SUPPRESSED CANCER CELLS
    Publication number: 20090311188
    Abstract: In vitro and in vivo methods for identifying compounds capable of targeting suppressed cancer cells such as micrometastatic cells. The in vitro method includes the steps of comparing the response to a test compound of cancer cells grown on a suppressing cell support matrix which causes suppression of a malignant phenotype in a growing cancer cell and on a non-suppressing cell support matrix. The in vivo method includes a step of co-injecting labeled cancer cells with a malignant-phenotype suppressing matrix into a test animal to produce suppressed micrometastatic cells therein.
    Type: Application
    Filed: August 13, 2009
    Publication date: December 17, 2009
    Inventors: Robert E. Hurst, Michael A. Ihnat
  • Method of identification of compounds effective against suppressed cancer cells
    Patent number: 7575926
    Abstract: A method for identifying compounds capable of targeting suppressed cancer cells, the method including the steps of comparing the response to a test compound of cancer cells grown on a suppressing cell support matrix which causes suppression of a malignant phenotype in a growing cancer cell and on a non-suppressing cell support matrix.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: August 18, 2009
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Robert E. Hurst, Michael A. Ihnat, Kimberly D. Kyker